Of the 16 million American adults who live with depression, as many as one-quarter gain little or no benefit from available treatments, whether drugs or talk therapy. They represent perhaps the greatest unmet need in psychiatry. On Tuesday, the Food and Drug Administration approved a prescription treatment intended to help them, a fast-acting drug derived… Read More »
New research could help to explain why some people report that they experience sensation in a missing limb, following amputation. Most people who have an amputation will experience phantom limb sensations, and new research helps explain why. Phantom limb is the sensation that the missing part remains attached. The vast majority of people with amputation… Read More »
Antidepressant could ‘improve old age for millions’ by slowing the progression of Alzheimer’s and Parkinson’s First human trails of drug trazodone’s effects on the diseases will start this year Results in mice suggest it could slow neurodegenerative conditions Researchers expect to confirm if it is an effective treatment within five years By Rosie Taylor for the Daily… Read More »
A new rapid test for earlier diagnosis of sepsis is being developed by University of Strathclyde researchers. The device, which has been tested in a laboratory, may be capable of producing results in two-and-a-half minutes, the Biosensors and Bioelectronics journal study suggests. Diagnosing sepsis can be a complex process. The UK Sepsis Trust said it… Read More »
For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »